Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2022 Filed Aug 8, 2022 20:30 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $4.49 | $36,342.06 |
DisclosureSEC source: 0001209191-22-044802 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 49,676 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,306 Underlying: Common Stock · 49,676 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on December 30, 2016, and became fully vested as of January 12, 2021. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 10,948 | $28.04 | $307,011.48 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,132 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.92 to $28.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 39,052 | $27.63 | $1,078,838.84 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,080 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.92 to $27.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 49,676 | $1.00 | $49,676.00 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 21, 2022 Filed Jul 25, 2022 20:16 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 79,768 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043105 · doc4.xml · derivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,441 Underlying: Common Stock · 79,768 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 27, 2017 and fully vested on April 27, 2021. Read SEC document |
| July 21, 2022 Filed Jul 25, 2022 20:16 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 79,768 | $27.50 | $2,193,620.00 |
DisclosureSEC source: 0001209191-22-043105 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,211 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 21, 2022 Filed Jul 25, 2022 20:16 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 79,768 | $1.00 | $79,768.00 |
DisclosureSEC source: 0001209191-22-043105 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 20:07 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 4,558 | $26.68 | $121,614.28 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,456 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.63 to $26.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 20:07 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 45,442 | $26.35 | $1,197,464.86 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.63 to $26.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:03 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-042547 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,021 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:03 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $26.57 | $215,089.96 |
DisclosureSEC source: 0001209191-22-042547 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.265 to $26.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:03 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $4.49 | $36,342.06 |
DisclosureSEC source: 0001209191-22-042547 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:03 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-042547 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,115 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:03 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $26.25 | $212,429.46 |
DisclosureSEC source: 0001209191-22-042547 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.09 to $26.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:03 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $4.49 | $36,342.06 |
DisclosureSEC source: 0001209191-22-042547 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:51 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 319,071 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041801 · doc4.xml · derivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,209 Underlying: Common Stock · 319,071 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 27, 2017 and fully vested on April 27, 2021. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:51 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 319,071 | $25.00 | $7,976,775.00 |
DisclosureSEC source: 0001209191-22-041801 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,211 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:51 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 319,071 | $1.00 | $319,071.00 |
DisclosureSEC source: 0001209191-22-041801 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:36 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 41,187 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-041151 · doc4.xml · derivative · entry 7 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,209 Underlying: Common Stock · 41,187 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:36 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 35,791 | $23.07 | $825,569.52 |
DisclosureSEC source: 0001209191-22-041151 · doc4.xml · nonDerivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.01 to $23.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:36 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $22.25 | $120,052.37 |
DisclosureSEC source: 0001209191-22-041151 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,644 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.00 to $23.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:36 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 41,187 | $4.49 | $184,929.63 |
DisclosureSEC source: 0001209191-22-041151 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:36 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-041151 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,396 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:36 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $21.88 | $118,039.66 |
DisclosureSEC source: 0001209191-22-041151 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.665 to $22.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:36 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-041151 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:07 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 106,357 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-039598 · doc4.xml · derivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,280 Underlying: Common Stock · 106,357 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 27, 2017 and fully vested on April 27, 2021. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:07 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 106,357 | $22.50 | $2,393,032.50 |
DisclosureSEC source: 0001209191-22-039598 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,211 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:07 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 106,357 | $1.00 | $106,357.00 |
DisclosureSEC source: 0001209191-22-039598 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-039188 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,792 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $20.08 | $108,364.63 |
DisclosureSEC source: 0001209191-22-039188 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.81 to $20.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-039188 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-039188 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,188 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $19.88 | $107,255.75 |
DisclosureSEC source: 0001209191-22-039188 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.65 to $20.025, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-039188 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-036271 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,584 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $19.33 | $104,296.05 |
DisclosureSEC source: 0001209191-22-036271 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.25 to $19.635, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-036271 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-036271 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,980 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $20.90 | $112,766.69 |
DisclosureSEC source: 0001209191-22-036271 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.79 to $21.015, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-036271 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 01:07 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-033328 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,376 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 01:07 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $19.77 | $106,678.92 |
DisclosureSEC source: 0001209191-22-033328 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.66 to $19.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 01:07 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-033328 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:07 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-033328 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,772 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:07 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $19.58 | $105,641.81 |
DisclosureSEC source: 0001209191-22-033328 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.48 to $19.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:07 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-033328 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 25, 2022 Filed May 27, 2022 16:04 UTC |
SMITH MICHAEL LDirector
|
SaleCommon Stock | 145,874 | $19.53 | $2,849,458.95 |
DisclosureSEC source: 0001209191-22-032487 · doc4.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 4,126 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.500095 to $19.803329, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: These shares of common stock are held in the Michael L. Smith Revised and Amended Trust Dated August 1, 2011. Read SEC document |
| May 11, 2022 Filed May 12, 2022 20:01 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-028523 · doc4.xml · derivative · entry 7 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,168 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| May 11, 2022 Filed May 12, 2022 20:01 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $15.95 | $86,069.98 |
DisclosureSEC source: 0001209191-22-028523 · doc4.xml · nonDerivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.57 to $16.395, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.